MDT · News · 20261006N
Research and Development Expense
Medtronic plc · 2026-10-06 · Importance 44 · Surprise 24 · In source text
Medtronic reported $2.9 billion of R&D investment in fiscal 2026. The investment supports innovation across medical devices and growth areas including pulsed field ablation, surgical robotics, renal denervation, and diabetes technologies. The disclosed amount exceeds the $1.091 billion materiality threshold for revenue-based items.
Key facts
- Medtronic plc invested $2.9 billion in research and development in fiscal year 2026. source
- Medtronic plc is focusing on pulsed field ablation and diabetes separation as part of its growth strategy. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | realized | — | Medtronic plc invested $2.9 billion in research and development in fiscal year 2026. |